OICR11029 |
OICR11029 : Inhibitor of BCL6
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| BCL6 |
|
|
Inhibitor
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Selective against other BTB domains: BAZF (BCL6B) 1.40 uM,
FAZF, PLZF, Miz1, Kaiso, LRF > 10 uM.
Ou ...
Potency Cellular
In Vitro
BCL6
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acsmedchemlett.2c00502
In Vivo Validations
Mouse
Dose: 1 mg/Kg IV, 10 mg/Kg PO
Route of delivery:
Intravenous, Oral
Plasma half life:
3 h
Systemic clearance:
12 mL/min/Kg
Cmax:
4 uM
Bioavailability:
30%
Volume of Distribution at Steady-State:
0.4 L/Kg
DOI Reference: 10.1021/acsmedchemlett.2c00502
Negative Control Compounds
Chemical Information
| Molecular Formula | C26H25Cl2N7O5 |
| SMILEs | C[C@H]1COCCN1c1cc(NC(=O)Cn2cc(-c3cc(Cl)c(O)c(C(N)=O)c3)c3c(=O)n(C)cnc32)c(Cl)cn1 |
| InChI | InChI=1S/C26H25Cl2N7O5/c1-13-11-40-4-3-35(13)20-7-19(18(28)8-30-20)32-21(36)10-34-9-16(22-25(34)31-12-33(2)26(22)39)14-5-15(24(29)38)23(37)17(27)6-14/h5-9,12-13,37H,3-4,10-11H2,1-2H3,(H2,29,38)(H,30,32,36)/t13-/m0/s1 |
| Molecular weight | 585.13 Da |
| AlogP | 0.0 |
| HBond acceptors | 12 |
| HBond donors | 4 |
| Atoms | 65 |